Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 192

1.

Cost-Efficiency of Robotic Surgery.

Covens A, Köhler C, Nam JH, Naumann RW, Obermair A, Querleu D.

Int J Gynecol Cancer. 2016 Jul;26(6):992-3. doi: 10.1097/IGC.0000000000000747. No abstract available.

PMID:
27327148
2.

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy.

Obermair A, Brennan DJ, Baxter E, Armes JE, Gebski V, Janda M.

Gynecol Oncol Res Pract. 2016 Feb 9;3:1. doi: 10.1186/s40661-016-0023-8. eCollection 2016.

3.

Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.

Obermair A, Youlden D, Baade P, Janda M.

Asia Pac J Clin Oncol. 2016 May 27. doi: 10.1111/ajco.12508. [Epub ahead of print]

PMID:
27230709
4.

Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study.

Obermair H, Janda M, Obermair A.

Acta Obstet Gynecol Scand. 2016 Sep;95(9):1008-14. doi: 10.1111/aogs.12924. Epub 2016 Jun 10.

PMID:
27199208
5.

Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?

Kusters I, Williams M, Obermair A, Janda M.

J Community Support Oncol. 2015 Feb;13(2):55-61. doi: 10.12788/jcso.0109.

PMID:
25866984
6.

Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial.

Baker J, Janda M, Graves N, Bauer J, Banks M, Garrett A, Chetty N, Crandon AJ, Land R, Nascimento M, Nicklin JL, Perrin LC, Obermair A.

Gynecol Oncol. 2015 Jun;137(3):516-22. doi: 10.1016/j.ygyno.2015.03.048. Epub 2015 Mar 28.

PMID:
25827292
7.

Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial.

Baker J, Janda M, Gebski V, Forder P, Hogg R, Manolitsas T, Obermair A.

Gynecol Oncol. 2015 Apr;137(1):102-5. doi: 10.1016/j.ygyno.2015.02.008. Epub 2015 Feb 14.

PMID:
25684217
8.

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.

Brennan DJ, Hackethal A, Mann KP, Mutz-Dehbalaie I, Fiegl H, Marth C, Obermair A.

BMC Cancer. 2015 Feb 6;15:33. doi: 10.1186/s12885-015-1028-0.

9.

Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australia.

Tan YY, Spurdle AB, Obermair A.

J Pers Med. 2014 May 12;4(2):218-44. doi: 10.3390/jpm4020218.

10.

Consideration for safe and effective gynaecological laparoscopy in the obese patient.

Hackethal A, Brennan D, Rao A, Land R, Obermair A, Nicklin J, Garrett A, Nascimento M, Crandon A, Perrin L, Chetty N.

Arch Gynecol Obstet. 2015 Jul;292(1):135-41. doi: 10.1007/s00404-014-3600-2. Epub 2014 Dec 23.

PMID:
25534161
11.

Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer.

Beesley VL, Rowlands IJ, Hayes SC, Janda M, O'Rourke P, Marquart L, Quinn MA, Spurdle AB, Obermair A, Brand A, Oehler MK, Leung Y, McQuire L, Webb PM; Australian National Endometrial Cancer Study Group.

Gynecol Oncol. 2015 Jan;136(1):87-93. doi: 10.1016/j.ygyno.2014.11.006. Epub 2014 Nov 11.

PMID:
25448454
12.

Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.

Anuradha S, Webb PM, Blomfield P, Brand AH, Friedlander M, Leung Y, Obermair A, Oehler MK, Quinn M, Steer C, Jordan SJ.

Med J Aust. 2014 Sep 1;201(5):283-8.

PMID:
25163381
13.

Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial.

Hawkes AL, Quinn M, Gebski V, Armes J, Brennan D, Janda M; feMME Trial Committee, Obermair A.

Contemp Clin Trials. 2014 Sep;39(1):14-21. doi: 10.1016/j.cct.2014.06.014. Epub 2014 Jul 1.

PMID:
24999075
14.

Reply to J. Moline et al.

Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB.

J Clin Oncol. 2014 Jul 20;32(21):2278-9. doi: 10.1200/JCO.2014.55.8213. Epub 2014 Jun 9. No abstract available.

15.

Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer.

Rowlands IJ, Beesley VL, Janda M, Hayes SC, Obermair A, Quinn MA, Brand A, Leung Y, McQuire L, Webb PM; Australian National Endometrial Cancer Study Group.

Gynecol Oncol. 2014 May;133(2):314-8. doi: 10.1016/j.ygyno.2014.03.003. Epub 2014 Mar 11.

PMID:
24631452
16.

Comment on 'External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'.

Obermair A.

Br J Cancer. 2014 Dec 9;111(12):2375. doi: 10.1038/bjc.2014.8. Epub 2014 Jan 21. No abstract available.

17.

Can the use of quality assurance tools reduce the impact of surgical complications on the well-being of obstetricians and gynaecologists in Australia and New Zealand?

Varughese E, Janda M, Obermair A.

Aust N Z J Obstet Gynaecol. 2014 Feb;54(1):30-5. doi: 10.1111/ajo.12162. Epub 2013 Dec 23.

PMID:
24359293
18.

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB.

J Clin Oncol. 2014 Jan 10;32(2):90-100. doi: 10.1200/JCO.2013.51.2129. Epub 2013 Dec 9.

19.

Serum HE4 as a prognostic marker in endometrial cancer--a population based study.

Brennan DJ, Hackethal A, Metcalf AM, Coward J, Ferguson K, Oehler MK, Quinn MA, Janda M, Leung Y, Freemantle M; ANECS Group, Webb PM, Spurdle AB, Obermair A.

Gynecol Oncol. 2014 Jan;132(1):159-65. doi: 10.1016/j.ygyno.2013.10.036. Epub 2013 Nov 6.

PMID:
24211402
20.

The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.

Obermair A, Youlden DR, Baade PD, Janda M.

Int J Cancer. 2014 May 1;134(9):2211-22. doi: 10.1002/ijc.28537. Epub 2013 Oct 31.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk